A carregar...
Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells
Mitochondrial dysfunction plays a primary role in neurodevelopmental anomalies and neurodegeneration of Down syndrome (DS) subjects. For this reason, targeting mitochondrial key genes, such as PGC-1α/PPARGC1A, is emerging as a good therapeutic approach to attenuate cognitive disability in DS. After...
Na minha lista:
| Publicado no: | Front Genet |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609571/ https://ncbi.nlm.nih.gov/pubmed/31316549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2019.00606 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|